Search alternatives:
2016 decrease » 026 decrease (Expand Search)
wt decrease » we decrease (Expand Search), nn decrease (Expand Search), awd decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
_ 2016 » _ 2019 (Expand Search), _ 2015 (Expand Search), _ 2010 (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
2016 decrease » 026 decrease (Expand Search)
wt decrease » we decrease (Expand Search), nn decrease (Expand Search), awd decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
_ 2016 » _ 2019 (Expand Search), _ 2015 (Expand Search), _ 2010 (Expand Search)
5 wt » _ wt (Expand Search), 5 ht (Expand Search), i wt (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
Scatter plot for the absolute decrease in CS rates (A) and the relative decrease in CS rates (B) from 2008 to 2016 among hospitals in Guangzhou grouped by their baseline CS rates.
Published 2019“…One circle represents one hospital, with blue (<i>n</i> = 20), green (<i>n</i> = 36), orange (<i>n</i> = 34), and purple (<i>n</i> = 22) representing baseline CS rates of <30%, 30%–39%, 40%–49%, and ≥50%, respectively. The absolute decrease = the CS rate at baseline − the CS rate in Stage 2; the relative decrease = (the CS rate at baseline − the CS rate in Stage 2) ÷ the CS rate at baseline. …”
-
7
-
8
-
9
-
10
-
11
Decrease of locomotor activity in <i>Auts2</i> mutant mice during habituation.
Published 2016“…<p>(A) Spontaneous locomotor activity for habituation to the novel environment was measured every 5 min for 60 min. Auts2-deficient mice exhibited a decrease in exploratory behavior during the first 15 min. …”
-
12
-
13
-
14
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
-
15
-
16
-
17
-
18
-
19
-
20